12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • PharmaCyte Biotech PMCB shares rose 71.92% to $5.88 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.4 million.
  • AzurRx BioPharma AZRX shares increased by 50.85% to $0.8. The company's market cap stands at $74.1 million. As per the press release, Q2 earnings came out 2 days ago.
  • Novo Integrated Sciences NVOS stock moved upwards by 21.42% to $2.04. The company's market cap stands at $54.0 million.
  • BrainsWay BWAY shares moved upwards by 18.94% to $9.04. The company's market cap stands at $148.7 million.
  • Amryt Pharma AMYT shares moved upwards by 12.78% to $12.26. The market value of their outstanding shares is at $775.0 million.
  • PetVivo Holdings PETV shares increased by 12.09% to $3.15. The company's market cap stands at $22.2 million.

 

 

Losers

 

  • Sesen Bio SESN stock decreased by 7.29% to $1.4 during Wednesday's pre-market session. The market value of their outstanding shares is at $274.4 million.
  • Rani Therapeutics Hldgs RANI shares declined by 7.29% to $16.67. The market value of their outstanding shares is at $312.3 million.
  • Renalytix RNLX shares fell 6.05% to $25.5. The market value of their outstanding shares is at $920.9 million.
  • NeuroBo Pharmaceuticals NRBO stock declined by 5.79% to $3.42. The market value of their outstanding shares is at $76.2 million. The company's, Q2 earnings came out 2 days ago.
  • Sharps Compliance SMED stock declined by 5.76% to $9.0. The market value of their outstanding shares is at $154.4 million. As per the news, the Q4 earnings report came out today.
  • Nymox Pharmaceutical NYMX stock declined by 5.68% to $1.83. The company's market cap stands at $153.2 million. The company's, Q2 earnings came out 3 days ago.

 

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...